Protective Effects of Lactobacillus‐Derived Probiotics and Postbiotics on Renal and Reproductive Function in Escherichia coli–Infected Rats Saeid Sedghi, Zahra Keshtmand, Saba Hosseini Abstract ABSTRACTBackground Escherichia coli infections of the genitourinary tract are a major cause of renal and reproductive dysfunction in males, often impairing spermatogenesis and fertility. Probiotics and postbiotics have emerged as microbiota‐based interventions with strain‐specific immunomodulatory and antioxidant properties.ObjectivesThis experimental study evaluated the effects of a probiotic or postbiotic supplementation containing Lactobacillus helveticus, Lactobacillus rhamnosus, and Lactobacillus casei on renal and testicular tissues, as well as sperm parameters, in male Wistar rats infected with E. coli.MethodsTwenty‐eight male Wistar rats (200–220 g) were randomly assigned to four groups: control, E. coli–infected, E. coli + probiotic (109 CFU/mL), and E. coli + postbiotic (109 CFU/mL). Probiotic or postbiotic supplementation was administered orally (gavage) once daily for 35 consecutive days, starting immediately after the final day of bacterial challenge. Biochemical markers (urea, creatinine, sodium, potassium), histological changes, total antioxidant capacity (TAC), gene expression (IL‐6, TNF‐α, Bax, Bcl‐2), and sperm quality were assessed. Statistical analysis was performed using one‐way ANOVA with Tukey's post hoc test (p < 0.05).Results E. coli infection significantly impaired renal and testicular histology, elevated pro‐inflammatory and pro‐apoptotic gene expression, reduced TAC, and deteriorated sperm parameters. Probiotic and postbiotic supplementation mitigated these effects, restoring antioxidant capacity, enhancing Bcl‐2 expression, reducing IL‐6 and TNF‐α levels, and improving sperm viability and morphology. Histological evaluation confirmed partial recovery of kidney and testicular structures in treated groups.ConclusionMulti‐strain probiotic–postbiotic mixtures confer protective effects against infection‐induced oxidative stress, apoptosis, and inflammation in renal and testicular tissues, while improving sperm quality. These findings highlight their translational potential as adjunctive therapies for infection‐associated male infertility and renal impairment.Keywords: Escherichia coli, gene expression, kidney, postbiotic, probiotic, testis, Wistar rat A Lactobacillus‐derived probiotic and postbiotic mixture alleviates E. coli–induced renal and reproductive dysfunction by modulating oxidative stress, inflammatory responses, and apoptosis, leading to improved tissue integrity and sperm quality. Introduction Genitourinary tract infections represent a significant category of bacterial diseases affecting the urinary and reproductive systems. Among the causative agents, Escherichia coli remains the predominant pathogen. This facultative anaerobic, rod‐shaped Gram‐negative bacillus is a natural inhabitant of the intestinal microbiota in humans and animals; however, pathogenic strains are frequently implicated in gastrointestinal disturbances and extraintestinal infections (Peng et al. ). In the urinary tract, E. coli infection manifests as pyelonephritis when the upper tract is involved, or as cystitis when localized to the bladder. Urinary tract infections (UTIs) are among the most common bacterial illnesses worldwide and pose a substantial threat to adult health. In men, recurrent UTIs are closely associated with reproductive dysfunction, contributing to impaired fertility outcomes (Dolin et al. ; Govindarajan et al. ). Male infertility is a multifactorial condition influenced by genetic predisposition, environmental exposures, and infectious insults (Komijani et al. ). Evidence suggests that bacterial infections, through immune‐mediated responses and apoptotic pathways, play a pivotal role in disrupting spermatogenesis and testicular function. The testes, epididymis, and accessory glands are particularly vulnerable to microbial invasion, with E. coli being the most frequently identified pathogen in male reproductive tract infections (Coutton et al. ). Clinical and experimental studies further demonstrate a strong correlation between E. coli infection and deterioration of sperm quality, particularly with advancing age (Kaur and Prabha ; Tao et al. ). Although antibiotics remain the cornerstone of UTI management (Mändar et al. ), their long‐term efficacy is increasingly compromised by the emergence of antimicrobial resistance. Recurrent infections and reduced therapeutic responsiveness highlight the urgent need for alternative or adjunctive strategies (Souho et al. ; Chikindas et al. ). Probiotics have emerged as promising biotherapeutic agents, capable of modulating host microbiota and conferring protective health benefits through colonization, competitive exclusion, and attenuation of pathogen virulence (Suez et al. ; Paone and Cani ). Mechanistically, probiotics reinforce mucosal barriers, inhibit pathogen adhesion, and neutralize bacterial toxins (Adamkova ). Complementing these live microbial interventions, postbiotics—defined as nonviable microbial products or metabolic byproducts—exhibit diverse bioactive properties. Derived via fermentation or physicochemical processing, postbiotics encompass proteins, lipids, carbohydrates, vitamins, and metabolites such as short‐chain fatty acids. They exert immunomodulatory, antimicrobial, anti‐inflammatory, antioxidant, and anti‐proliferative effects, thereby offering therapeutic potential across diverse clinical and experimental contexts (Asefa et al. ; Keshtmand et al. ). Clinical evidence highlights the therapeutic utility of Lactobacillus strains in controlling genitourinary infections. In males, Lactobacillus species contribute to maintaining a balanced microbiota within the urinary and reproductive tract, where their production of lactic acid, hydrogen peroxide, and antimicrobial metabolites helps suppress pathogenic colonization and modulate local immune responses (Coutton et al. ; Komijani et al. ). Recent studies demonstrate that probiotic‐derived metabolites exert antimicrobial, antioxidant, and immunomodulatory effects, reinforcing their role as adjunctive strategies in infection prevention and male reproductive health (Cannarella et al. ; Zhu et al. ). Despite considerable progress in probiotic and postbiotic research, their functional potential in safeguarding male reproductive health remains insufficiently characterized. To date, no systematic investigations have assessed the impact of probiotic–postbiotic formulations on renal integrity, testicular function, and sperm quality under conditions of E. coli–induced infection. The present study seeks to bridge this critical gap by examining the therapeutic efficacy of a native Iranian probiotic and postbiotic—comprising Lactobacillus casei, Lactobacillus rhamnosus, and Lactobacillus helveticus—in male reproduction of Wistar rats experimentally challenged with E. coli. By integrating probiotic and postbiotic strategies, this work aims to generate novel insights into microbiota‐based interventions for infection‐associated male infertility, thereby advancing translational approaches to reproductive and urinary tract health. Materials and Methods Experimental Animals Twenty‐eight adults male Wistar rats (200–250 g) were obtained from Shahid Beheshti University (Tehran, Iran). Animals were acclimatized for 1 week in the animal facility of the Faculty of Basic Sciences, Islamic Azad University, Central Tehran Branch, under controlled conditions: 12 h light/dark cycle, ambient temperature of 23 ± 2∘C, and ad libitum access to food and water. All procedures were performed at consistent times of day to minimize circadian variation. Body weights were recorded using a digital scale prior to surgical interventions and behavioural assessments. Animal care and experimental procedures strictly adhered to institutional guidelines for the use of laboratory animals (Mändar et al. ). Ethical approval was obtained under code IR.IAU.CTB.REC.1401.091. Preparation of Multi‐Strain Probiotics and Postbiotics Probiotic and postbiotic powders were purchased from Takgen Company. Postbiotics were prepared according to the manufacturer's protocol. The probiotic mixture contained L. casei (IBRC‐M10784), L. rhamnosus (IBRC‐M11322), and L. helveticus (TG‐35). Postbiotics were prepared by suspending 1 g of powder in 10 mL sterile distilled water, incubating at 37°C for 24 h, centrifuging at 5000 rpm for 10 min, and filtering through a 0.22‐μm membrane to obtain cell free metabolites. Probiotics were reconstituted in sterile saline (1 g in 10 mL), vortexed thoroughly, and adjusted to 1 × 109 CFU/mL using McFarland standards. Bacterial Culture Pathogenic E. coli strains were obtained from the Genetic Resources Center of Iran. Cultures were grown on Eosin Methylene Blue (EMB) and MacConkey agar (Merck, Germany) at 37°C for 24 h. Seven E. coli colonies (two lactose‐negative and five lactose‐positive) that were biochemically characterized using TSI, Simon Citrate, MR‐VP, and EMB/MacConkey morphology were pooled and used as the challenge inoculum. Phenotypic identification was selected because the aim of this study was to confirm pathogenic characteristics relevant to infection induction rather than molecular strain typing. For infection preparation, bacteria were cultured in tryptic soy broth (TSB) at 37°C for 24 h, centrifuged at 2000 rpm for 20 min (Behdad, Iran), washed with 0.5× phosphate‐buffered saline (PBS), and resuspended (Peng et al. ). Optical density was adjusted to OD630 = 0.5 using a spectrophotometer (Thermo Scientific, USA), corresponding to 1 × 108 CFU/mL. Each rat received 1 mL of bacterial suspension orally for 3 consecutive days. Experimental Design A total of 28 Wistar male rats, which were kept under the mentioned conditions, were distributed into four groups: (1) the control group, (2) infected with E. coli (108 CFU/mL), (3) the infected model + receiving postbiotic (109 CFU/mL), and (4) infected model + receiving probiotic (109 CFU/mL). Body weight was recorded on days 0, 18, and 35 of the experiment. Probiotic or postbiotic supplementation was administered orally (gavage) once daily for 35 consecutive days, starting immediately after the final day of bacterial challenge. At the end of the experimental period, testicular weight was measured using a digital scale, and testicular volume was assessed using callipers to ensure accurate morphometric evaluation. Biochemical Study At the end of the study, rats were anesthetized with ketamine (87 mg/kg) and xylazine (13 mg/kg). Blood samples were collected via cardiac puncture, and kidneys and testes were excised for histological, molecular, and antioxidant analyses. Serum was separated by centrifugation at 4000 rpm for 10 min at room temperature (Komijani et al. ). Biochemical parameters (creatinine, sodium, potassium, and urea) were measured using commercial assay kits (Pars Azmoon, Iran) and analyzed with an autoanalyzer (Hitachi, Japan). Examination of Kidney and Testicle Histology Kidney and testis tissues were collected immediately after euthanasia. Tissue fragments (3–5 mm) were fixed in 4% paraformaldehyde for 24 h, dehydrated through graded ethanol, cleared in xylene, and embedded in paraffin. Paraffin blocks were sectioned at 5‐μm thickness using a rotary microtome. Routine haematoxylin and eosin (H&E) staining was performed for general histological evaluation, and periodic acid–Schiff (PAS) staining was applied to kidney sections to assess basement membrane integrity (Li et al. ). Images were captured at 100× magnification using an automated slide‐scanning system (Axio Scan Z1; Zeiss Korea, Seoul, Korea). Histological evaluation was performed independently by three blinded pathologists, and inter‐observer agreement was assessed (κ = 0.82), confirming high reliability of scoring. Sperm Extraction Fragments of the epididymis were placed in a plate containing sperm‐specific culture medium and distilled water, then mechanically minced. After complete homogenization, the suspension was incubated for 20 min. The sperm solution was transferred onto a slide and stained with Papanicolaou and Eosin Y dyes (Merck, Germany). Finally, a neobar slide was used to count spermatozoa (Coutton et al. ). Measurement of the Total Antioxidant Capacity Total Antioxidant Capacity (TAC) levels in kidney and intestinal tissues were measured using a TAC kit (Naxifer, Iran). Approximately 50–100 mg of tissue was weighed, and lysing buffer was added at a volume 10 times the tissue weight. Samples were homogenized and centrifuged at 10,000 rpm for 10 min, after which the supernatants were collected for analysis. Subsequent steps were performed according to the kit protocol. A standard sample was included alongside the test samples. Optical absorption was measured at 593 nm as the final step (RahimBakhsh et al. ). Investigation of Gene Expression by Real‐Time Polymerase Chain Reaction Method The expression of apoptotic and inflammatory genes was quantified by real‐time polymerase chain reaction (PCR). Total RNA was extracted using RNX‐plus reagent (SinaClon, Iran). cDNA synthesis was performed from 1000 ng RNA using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, USA). PCR reactions were conducted in duplicate in 25 μL volumes with SYBR Green Master Mix (Amplicon, Denmark). GAPDH served as the internal control. Relative gene expression was calculated using the ΔΔCt method with the REST software (Tao et al. ). Primer sequences are listed in Table . Primer sequences were designed using standard primer design software and validated through NCBI Primer‐BLAST to ensure specificity and absence of off‐target amplification. Statistical Analysis All statistical analyses were performed using SPSS version 23 (IBM Corp., Armonk, NY, USA). Data were expressed as mean ± standard deviation (SD). Group comparisons were conducted using one‐way analysis of variance (ANOVA). When significant differences were detected, Tukey's honest significant difference (HSD) post hoc test was applied to evaluate pairwise differences in biochemical parameters, histological scores, sperm characteristics, antioxidant capacity, and gene expression levels. A threshold of p < 0.05 was considered statistically significant. Results Biochemical Identification of E. coli Biochemical characterization confirmed the identity of the bacterial isolate as E. coli. In triple sugar iron (TSI) medium, glucose fermentation and gas production were positive, whereas hydrogen sulphide production was absent. Simon citrate and Voges–Proskauer (VP) tests were negative, while the Methyl Red (MR) test was positive. Collectively, these results verified the presence of E. coli in the cultures. Histological Findings in Kidney Tissue Histopathological evaluation of kidney sections stained with H&E (Figures and ; Table ) revealed distinct differences among the experimental groups. In the control group (Figure ), renal architecture was preserved, with intact glomeruli; normal tubular epithelium; and absence of vacuolar degeneration, haemorrhage, or necrosis. In contrast, the E. coli–infected group (Figure ) exhibited marked pathological changes, including vacuolar degeneration, extensive haemorrhage, collagen fibre deposition, cellular necrosis, and pronounced lymphocyte infiltration. These alterations were consistent with severe infection‐induced renal injury. Treatment with probiotics (Figure ) or postbiotics (Figure ) attenuated these pathological changes. Both groups demonstrated partial restoration of renal histology, with reduced vacuolization, diminished inflammatory infiltration, and improved glomerular structure compared with the infected group. Although tissue damage was not completely resolved, probiotic and postbiotic supplementation clearly promoted histological recovery. Histological Findings in Testicular Tissue Histological evaluation of testicular sections stained with H&E (Figure ; Table ) revealed marked differences among the experimental groups. In the control group (Figure ), seminiferous tubules exhibited normal morphology with intact germinal epithelium, well‐organized cell layers, preserved nuclei and cytoplasm, and regular lumen diameter, indicating healthy testicular architecture. In contrast, the E. coli–infected group (Figure ) displayed severe pathological alterations, including disruption of the germinal epithelium, accumulation of inflammatory cells, reduction in seminiferous tubule size, and destruction of luminal structure. These findings confirm infection‐induced testicular damage and impaired spermatogenic integrity. Treatment with probiotics (Figure ) or postbiotics (Figure ) attenuated these pathological changes. Both groups demonstrated partial restoration of seminiferous tubule morphology, reduced inflammatory infiltration, and improved germinal epithelium organization compared with the infected group. Although complete recovery was not achieved, probiotic and postbiotic supplementation clearly promoted histological repair and preservation of testicular tissue integrity. In Table , the decrease in testicular weight, testicular volume, and seminiferous tubule diameter in the E. coli–infected group compared to the control group was statistically significant. All measurements were performed at the end of the experimental period using callipers. In contrast, lumen diameter and germ cell layer thickness showed a significant increase in the infected group relative to controls. Probiotic and postbiotic treatments partially restored these parameters toward normal values, indicating their protective effects against E. coli–induced testicular injury. Chemical Serum Factors Result As shown in Figure , serum urea levels were significantly elevated in the E. coli–infected group compared with the control group (p < 0.001). Similarly, rats receiving E. coli in combination with probiotics and postbiotics exhibited higher urea levels than controls (p < 0.01). However, probiotic–postbiotic treatment significantly reduced urea concentrations compared with the E. coli‐only group (p < 0.05). Potassium levels followed a comparable trend (Figure ), with significant increases in the E. coli–infected and treated groups relative to controls, though the magnitude of change differed across groups (varying p‐values). As illustrated in Figure , serum creatinine concentrations were markedly elevated in the E. coli–infected group (p < 0.001) and in the E. coli + probiotic–postbiotic group (p < 0.05) compared with controls. Importantly, probiotic–postbiotic supplementation significantly reduced creatinine levels relative to the E. coli‐only group (p < 0.01). In contrast, sodium concentrations did not differ significantly among any of the experimental groups (Figure ), indicating that infection and treatment did not alter serum sodium homeostasis. Total Antioxidant Capacity Results As shown in Figure , TAC levels in kidney tissue were significantly reduced in the E. coli–infected group compared with the control group (p < 0.001). Animals receiving E. coli in combination with probiotics and postbiotics also exhibited a significant reduction in TAC relative to controls (p < 0.05). Interestingly, treatment with postbiotics alone resulted in a modest increase in TAC compared with controls, although this difference did not reach statistical significance (p > 0.05). Importantly, probiotic–postbiotic supplementation significantly improved TAC levels compared with the E. coli‐only group (p < 0.001), indicating a restorative effect of the intervention. These findings were consistent with TAC measurements in testicular tissue (Figure ), where E. coli infection markedly reduced antioxidant capacity, and probiotic–postbiotic treatment partially restored TAC values toward control level. Kidney and Testis Apoptotic Gene Expression As shown in Figure , Bax gene expression in kidney tissue was significantly elevated in the E. coli–infected group compared with the control group (p < 0.001). Both probiotic‐treated and postbiotic‐treated groups also showed increased Bax expression relative to controls (p < 0.05). However, treatment with either probiotic or postbiotic markedly reduced Bax expression compared with the E. coli‐only group (p < 0.001), indicating a protective effect against infection‐induced apoptosis. Consistent findings were observed in testicular tissue (Figure ), where Bax expression followed a similar pattern with minor variations in statistical significance. Analysis of Bcl‐2 gene expression revealed an opposite trend. In kidney tissue (Figure ), Bcl‐2 expression was significantly upregulated in the E. coli–infected group (p < 0.01) and further elevated in the probiotic–postbiotic treatment group (p < 0.001) compared with controls. Importantly, probiotic–postbiotic supplementation significantly increased Bcl‐2 expression relative to the E. coli‐only group (p < 0.01), suggesting enhanced anti‐apoptotic activity. Similar results were obtained in testicular tissue (Figure ). Escherichia coli infection, as well as probiotic and postbiotic treatments, significantly increased Bcl‐2 expression compared with controls (p < 0.001). Moreover, Bcl‐2 levels were further elevated in the probiotic (p < 0.01) and postbiotic (p < 0.001) groups compared with the infected group, reinforcing the protective role of these interventions in maintaining testicular integrity. Kidney and Testis Inflammatory Gene Expression Analysis of interleukin‐6 (IL‐6) expression in kidney tissue (Figure ) revealed a significant upregulation in the E. coli–infected group compared with controls (p < 0.01). In contrast, probiotic‐ and postbiotic‐treated groups did not show significant increases relative to controls. Notably, combined probiotic or postbiotic supplementation significantly reduced IL‐6 expression compared with the E. coli‐only group (p < 0.001), indicating a strong anti‐inflammatory effect. In testicular tissue (Figure ), IL‐6 expression was markedly elevated in the E. coli–infected group (p < 0.001). Probiotic (p < 0.05) and postbiotic (p < 0.01) treatments significantly decreased IL‐6 levels compared with the infected group, suggesting partial restoration of inflammatory balance. Tumour necrosis factor‐alpha (TNF‐α) expression in kidney tissue (Figure ) was significantly increased in the E. coli–infected group compared with the controls (p < 0.001). However, probiotic and postbiotic treatments did not differ significantly from controls. Importantly, TNF‐α expression was significantly reduced in both treatment groups compared with the E. coli‐only group (p < 0.01), further supporting their anti‐inflammatory role. In testicular tissue (Figure ), TNF‐α expression was strongly elevated in the E. coli–infected group relative to controls (p < 0.001). Probiotic and postbiotic treatments also showed increased TNF‐α levels compared with controls (p < 0.001), but combined probiotic–postbiotic supplementation significantly reduced TNF‐α expression compared with the infected group (p < 0.001). Sperm Analysis As summarized in Tables , , , sperm parameters were markedly affected by E. coli infection. In the control group, testicular tissue exhibited normal spermatogenesis, with intact sperm number, viability, and morphology, indicating healthy reproductive function. In contrast, the E. coli‐infected group demonstrated significant impairments, including reduced spermatogenesis, decreased sperm viability, and abnormal morphology, consistent with infection‐induced reproductive damage. Notably, rats treated with probiotics or postbiotics in conjunction with E. coli infection exhibited partial restoration of sperm quality. Both treatment groups showed improvements in spermatogenesis, viability, and morphology compared with the E. coli‐only group, suggesting that probiotic and postbiotic supplementation mitigated infection‐related damage and promoted relative repair of testicular function. In addition, the number of spermatogonia, primary and secondary spermatocytes, and diameter of seminiferous tubules remained unchanged in the control group, while in the group infected with bacteria, the most damage was observed in each of these parameters. Discussion The global escalation of antibiotic resistance has transformed bacterial infections into a critical challenge for modern medicine. Conventional antibiotic therapies, while effective in acute management, often disrupt commensal microbial communities, thereby facilitating the persistence of resistant strains. Moreover, systemic dissemination of pathogens such as E. coli can lead to septicaemia, significantly increasing morbidity and mortality rates (Gutiérrez et al. ). Virulence factors including toxins, capsules, and pili genes have been implicated in the pathogenesis of urinary tract infections (Çiftci and Tuna ), underscoring the need for alternative therapeutic strategies that both suppress pathogenic activity and preserve host microbial balance. In this study, we demonstrated that E. coli infection in male Wistar rats induced profound renal and testicular damage, accompanied by biochemical alterations, oxidative stress, and dysregulation of apoptotic and inflammatory gene expression. Specifically, infection elevated serum urea and creatinine, reduced total antioxidant capacity (TAC), and triggered histological degeneration in kidney and testis tissues. At the molecular level, E. coli infection upregulated pro‐apoptotic Bax and pro‐inflammatory cytokines (TNF‐α, IL‐6), while downregulating the anti‐apoptotic gene Bcl‐2, consistent with infection‐induced apoptosis and inflammation. Importantly, supplementation with a native probiotic–postbiotic mixture (L. casei, L. rhamnosus, and L. helveticus) mitigated these deleterious effects (Keshtmand et al. ). Both probiotics and postbiotics improved TAC, reduced serum biochemical markers, and partially restored tissue architecture. Furthermore, treatment downregulated Bax, TNF‐α, and IL‐6, while upregulating Bcl‐2, suggesting a dual role in modulating apoptosis and inflammation. These findings highlight the therapeutic potential of microbiota‐based interventions in protecting renal and reproductive function against E. coli–induced injury (Zhang et al. ). Our results align with previous studies demonstrating the beneficial effects of Lactobacillus strains on reproductive and systemic health. Moreover, Dardmeh et al. () revealed beneficial benefits on male reproductive hormone levels and testicular tissue after feeding hypercholesterolemic male rats a diet supplemented with Lactobacillus acidophilus. According to Vílchez et al. (), Anguilla's spermatogenesis processes improved after receiving L. rhamnosus treatment for 2 weeks, as shown by transcriptome analysis and sperm parameter evaluation (Vílchez et al. ). Duarte et al. () demonstrated that synbiotic supplementation improved growth performance and reduced oxidative stress and diarrhoea in piglets challenged with enterotoxigenic E. coli (Duarte et al. ). Similarly, previous studies reported that probiotic mixtures significantly reduced oxidative stress and inflammatory cytokines, including IL‐6, in both gastrointestinal and systemic disease models (Cannarella et al. ; Zhu et al. ; Chen et al. ). Mechanistically, probiotics and postbiotics exert protective effects through multiple pathways. These include competitive exclusion of pathogens, production of antimicrobial compounds (bacteriocins, organic acids), reinforcement of epithelial barrier integrity, and modulation of host immune responses (Monteagudo‐Mera et al. ; Teame et al. ). Probiotics also regulate toll‐like receptor (TLR) signalling, dendritic cell activity, and cytokine production, thereby balancing innate and adaptive immunity (Mazziotta et al. ; Liu et al. ). The synergistic use of multiple strains, as in our study, may amplify these effects by combining diverse metabolic and immunomodulatory properties (C. Lee, Kim, et al. ) (Wang et al. ). After an 8‐week treatment with a probiotic mixture containing Lactobacillus salivarius, L. casei, and Bifidobacterium bifidum, the study reported a significant reduction in serum IL‐6 and other pro‐inflammatory cytokines (Wierzbicka et al. ). Recent advances in microbiome research have highlighted the multifaceted role of probiotics in modulating host immune responses and protecting against pathogenic infections. Probiotics, particularly Lactobacillus strains, exert beneficial effects through diverse mechanisms, including cytokine regulation, enhancement of innate and adaptive immunity, and reinforcement of epithelial barrier integrity. For example, Yeşilyurt et al. () demonstrated that probiotics enhance cytokine production, increase immunoglobulin levels, stimulate mononuclear cell proliferation, and elevate natural killer cell activity, while also activating macrophages. Similarly, Begum et al. () reported that probiotics modulate autoimmunity and strengthen host defences against bacterial and protozoal pathogens. Importantly, the concurrent use of multiple probiotic strains has been shown to produce synergistic immunological benefits, amplifying the overall protective response (J. Lee, Jo, et al. ). Our findings demonstrate that probiotic–postbiotic supplementation effectively attenuated E. coli–induced renal and testicular damage in male Wistar rats. Treatment reduced pro‐inflammatory cytokine expression (TNF‐α, IL‐6), downregulated the pro‐apoptotic marker Bax, and upregulated the anti‐apoptotic gene Bcl‐2, thereby contributing to the restoration of tissue homeostasis. These results are consistent with previous reports; for example, Li et al. () showed that pretreatment with L. rhamnosus protected against E. coli–induced mastitis by lowering TNF‐α and IL‐1β levels, highlighting the immunomodulatory potential of probiotics in infection models. Similarly, our observation of improved sperm quality and modulation of apoptotic gene expression parallels the findings of Keshtmand et al. (), who reported protective effects of L. casei and Bifidobacterium lactis on sperm parameters in diabetic rats. Taken together, these studies reinforce the translational relevance of probiotic–postbiotic interventions in mitigating infection‐associated oxidative stress, apoptosis, and reproductive dysfunction. These findings are consistent with previously reported murine experimental models of E. coli infection, which similarly demonstrate marked inflammatory and apoptotic responses following bacterial challenge (Peng et al. ). Beyond their immunomodulatory activity, probiotics contribute to maintaining microbial balance within the male genitourinary tract, where their antimicrobial metabolites help limit pathogenic colonization and support tissue homeostasis. In the context of the E. coli challenge model, the modulatory effects of probiotic and postbiotic supplementation are best interpreted through their capacity to regulate host inflammatory and apoptotic responses rather than through broad mechanistic pathways. Both interventions attenuated infection‐induced tissue injury by reducing pro‐apoptotic signalling and preserving epithelial integrity, consistent with murine models demonstrating similar protective effects against E. coli–mediated renal and reproductive damage (Vinayamohan et al. ; Hreha et al. ). This targeted modulation of host responses highlights the relevance of probiotic‐ and postbiotic‐derived metabolites in mitigating bacterial challenge–associated dysfunction. Taken together, our study provides novel evidence that probiotic–postbiotic supplementation protects against E. coli–induced renal and testicular injury by enhancing antioxidant defences, modulating apoptosis, and suppressing inflammation. These findings reinforce the growing consensus that probiotics and postbiotics represent promising adjuncts or alternatives to antibiotics, particularly in the era of escalating resistance. Future research should focus on clinical translation, including dose optimization, strain selection, and long‐term safety evaluation, to fully harness the therapeutic potential of microbiota‐based interventions. Conclusion The present study demonstrates that supplementation with a probiotic–postbiotic mixture (L. casei, L. rhamnosus, and L. helveticus) exerts protective effects against E. coli–induced renal and testicular damage in male Wistar rats. These benefits appear to be mediated through multiple mechanisms, including enhancement of antioxidant defences, inhibition of toxic compound activity, scavenging of free radicals, and modulation of inflammatory and immune responses. Our findings suggest that probiotics and postbiotics may serve as promising adjuncts or alternatives to conventional therapies for mitigating infection‐related tissue injury and potentially reducing the harmful impacts of environmental pollutants and pathogenic microorganisms. Nevertheless, further investigations are required to define the optimal strains, dosages, and timing of administration, as well as to evaluate long‐term safety and efficacy. Rigorous preclinical and clinical studies will be essential to translate these results into practical applications for human health and to establish microbiota‐based interventions as feasible candidates in the prevention and treatment of infection‐induced infertility and renal dysfunction. Ethics Statement Ethical approval was obtained under code IR.IAU.CTB.REC.1401.091.